Alternative Natural Therapy Relaxation and Acupuncture Clinic Logo

Manufacturing “Madness”: The Pseudoscience of Modern Psychiatry

MISSION STATEMENT: “I aim to get my patients as WELL as possible, as quickly as possible, and then to keep them WELL”.

Volumes of solid scientific evidence collected over the last quarter-century demonstrate that mood altering SSRIs carry serious and sometimes deadly side effects. Shockingly, evidence indicates that SSRI use in patients can, in fact, increase the length of bouts of depression and significantly promote relapse. A meta-analysis appearing in the British Medical Journal, which pooled data from more than 700 studies and 87,650 patients, found that that there exists an “association between the use of SSRIs and increased risk of fatal and non-fatal suicide attempts.”  Numerous studies show that SSRIs are generally no more effective than a placebo (sugar pill) in treating depression. Of the nearly 300 fabricated mental disorders outlined in the DSM-5, not one of them is based on objective data drawn from double-blind, placebo-controlled studies. In short, before you swallow tablets based on a 15 minute examination of your very complex life, realise Psychiatric Drugs are Dangerous, Psychiatric Drugs are NOT Effective, Psychiatric Diagnoses Have No Basis in Science, and that The Psychiatric Establishment is Bought and Paid for by Big Pharma, actually Bad Pharma. The Father on Modern Medicine Hippocrates said “First, do NO harm” and also wisely stated “Let your medicine be your food and your food your medicine”. Big Bad Pharma apparently does NOT agree. My name is Louis Gordon and I am an acupuncturist. I practice acupuncture from ANTRAC Acupuncture Clinic in Middle Ridge, Toowoomba, Queensland, 4350, Australia. Just as fresh clean water bubbling up from a natural well is vital to sustain life, my WELLNESS information will help YOU to sustain a vibrant life beaming with emotional stability and optimal wellness.

1360310678_Facebook1360314606_Twitter1360314763_youtube_oldAcupuncture YouTube video channel for Acupuncture videos.1360323267_Linkedin

Twenty-six years have passed since Prozac, the antidepressant drug, was introduced to the US market and quickly achieved the label of a “wonder drug.” In the decade that followed, other antidepressant drugs including paroxetine (Paxil), sertraline (Zoloft), fluvoxamine (Luvox), and citalopram (Celexa) would be released, creating an entire class of medications known as selective serotonin reuptake inhibitors (SSRIs). Since hitting the shelves, the popularity of SSRIs has skyrocketed. Today, 1 in every 10 Americans reaches for antidepressants daily. This ratio jumps to an incredible 25% among women between the ages of 40 and 59. Approximately 5% of children ages 12 to 19 are also taking antidepressants. Worldwide, mental illness is now the leading cause of disability among children.

Active members and veterans of the US military have become especially dependent on psychiatric meds. Today, about 1 in 6 service members is using antidepressants, sedatives, and other psychiatric drugs in an attempt to cope with post-traumatic stress disorder and other afflictions. From 2001-2009 alone, psychiatric drug use in this demographic rose by 76% and in 2010 alone, the Pentagon spent more than $280 million on psychiatric drugs.

Along with the rise in antidepressant use in recent years, we have witnessed the creation of many new clinical diagnoses in the field of psychiatry. What would have been considered just a few years ago to be rebellious behaviour among teenagers is now termed Oppositional Defiant disorder; what was once looked upon as a child not wanting to do maths homework is now classified as Mathematics Disorder. As the psychiatric establishment increasingly asserts its importance by pathologising normal human behaviour, tens of millions of Americans are popping pills in an attempt to find mental wellbeing. All the while, Big Pharma is making a killing; in 2010 alone, SSRI sales topped $70 billion.

Considering how widely SSRIs are prescribed, you would be forgiven for thinking that this class of drugs is highly safe and effective. In point of fact, these drugs come with a host of devastating and sometimes deadly health implications. Examining the state of the medical industrial complex deeper still makes one thing abundantly clear: Psychiatry is NOT a science but a massively destructive unscientific experiment fuelled by a medical industrial complex that values profits over human life and wellbeing.

Let’s break it down:

FACT: Psychiatric Drugs are Dangerous

Volumes of solid scientific evidence collected over the last quarter-century demonstrate that SSRIs carry serious and sometimes deadly side effects. These adverse effects include akathisia (a condition in which a person feels compelled to move about), permanent neurological damage, bone fracture, birth defects, sexual dysfunction, suicide (especially in children and teenagers) and acts of violence. Shockingly, evidence indicates that SSRI use in patients can, in fact, increase the length of bouts of depression and significantly promote relapse.

Especially concerning is the alarming link between suicides and psychiatric drug use. At present, 22 US veterans commit suicide each day.] In fact, more active-duty American soldiers are ending their own lives than are dying in combat. Could it be that the rising rates of suicide among members of the US military are actually being fuelled by SSRI and other psychiatric medicine use? A body of research suggests that the answer is yes.

A meta-analysis appearing in the British Medical Journal, which pooled data from more than 700 studies and 87,650 patients, found that that there exists an “association between the use of SSRIs and increased risk of fatal and non-fatal suicide attempts.” The researchers stated in their conclusion that methodological limitations may have caused them to actually underestimate the real risk of suicide attempts.

It has been ten years since the FDA required SSRI manufactures to place a black box label on their drugs stating suicide as a side effect of taking this class of drugs. How many more deaths have to occur before the FDA bans these dangerous pills?

FACT: Psychiatric Drugs are NOT Effective

Numerous studies show that SSRIs are generally no more effective than a placebo (sugar pill) in treating depression. The authors of a 2008 meta-analysis examining the effectiveness of using SSRIs in patients with depression remarked that:

“These findings suggest that, compared with placebo, the new-generation antidepressants do not produce clinically significant improvements in depression in patients who initially have moderate or even very severe depression, but show significant effects only in the most severely depressed patients.”

Upon closer investigation, it’s little wonder that these drugs aren’t efficacious. Psychiatric authorities still contend that mental illness has its roots in “chemical imbalances” in the brain (particularly related to levels of serotonin) that may be mediated through pharmaceuticals. The only problem with this is the fact that no compelling evidence exists to confirm this hypothesis. A growing body of evidence actually debunks the chemical imbalance theory altogether. Further still, studies have proven that SSRIs disturb normal brain function, ultimately reducing the brain’s ability to respond to serotonin. This is a possible reason that individuals on SSRIs are more likely to suffer from depression for longer periods of time, and relapse more frequently.

FACT: Psychiatric Diagnoses Have No Basis in Science

The American Psychiatric Association’s Fifth Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) is the definitive guide for psychiatric diagnoses. Of the nearly 300 mental disorders outlined in the DSM-5, not one of them is based on objective data drawn from double-blind, placebo-controlled studies. Rather, the criteria for determining mental illness are based solely on subjective described behaviour.

There are no blood tests, no brain scans or urine samples- not one biological marker to validate the existence of these so-called conditions.

The flawed nature of mental health diagnoses has been pointed out for years. In a 2010 opinion piece for the LA Times, Allen Frances, chairman of the taskforce that created the DSM-4, commented on the absurdity of the ever-expanding pool of mental disorders stating the following:

The first draft of the next edition of the DSM, posted for comment with much fanfare last month, is filled with suggestions that would multiply our mistakes and extend the reach of psychiatry dramatically deeper into the ever-shrinking domain of the normal. This wholesale medical imperialisation of normality could potentially create tens of millions of innocent bystanders who would be mislabelled as having a mental disorder. The pharmaceutical industry would have a field day – despite the lack of solid evidence of any effective treatments for these newly proposed diagnoses.

Even more damning was a deathbed confession in 2009 by the eminent child psychiatrist, Dr. Leon Eisenberg. In his final interview, Eisenberg reportedly revealed that “ADHD is a prime example of a fictitious disease.” The bombshell came at the end of Eisenberg’s long career developing foundational theories in modern psychiatry that led to the creation of ADHD and other mental disorders.

Given the lack of scientific rigour with which the APA concocts new disorders, it shouldn’t come as any surprise that the DMS-5 even outlines “caffeine use disorder” and “internet gaming disorder” as conditions that warrant further study. The bottom line is that psychiatry’s diagnostic handbook has as much credibility as a comic book.

FACT: The Psychiatric Establishment is Bought and Paid for by Big Pharma

Like the other branches of the medical-industrial complex, psychiatry is infested with conflicts of interest. One of the most outspoken critics of the pharmaceutical industry’s extensive influence over modern medicine is Dr. Marcia Angell, the former editor-in-chief of the New England Journal of Medicine who now serves as a senior lecturer in social medicine at Harvard Medical School.

In an essay written for The New York Book Review. Dr. Angell recounts the systemic corruption that has plagued the field of psychiatry:

As psychiatry became a drug-intensive specialty, the pharmaceutical industry was quick to see the advantages of forming an alliance with the psychiatric profession. Drug companies began to lavish attention and largesse on psychiatrists, both individually and collectively, directly and indirectly. They showered gifts and free samples on practicing psychiatrists, hired them as consultants and speakers, bought them meals, helped pay for them to attend conferences, and supplied them with “educational” materials. When Minnesota and Vermont implemented “sunshine laws” that require drug companies to report all payments to doctors, psychiatrists were found to receive more money than physicians in any other specialty. The pharmaceutical industry also subsidises meetings of the APA and other psychiatric conferences. About a fifth of APA funding now comes from drug companies.

Dr. Angell goes on to describe how pharmaceutical companies manipulate study results to maximize profit streams from their drugs:

… drug companies make very sure that their positive studies are published in medical journals and doctors know about them, while the negative ones often languish unseen within the FDA, which regards them as proprietary and therefore confidential. This practice greatly biases the medical literature, medical education, and treatment decisions.

Upon further investigation we find that not only are unflattering study outcomes concealed while positive ones are publicised, but Big Pharma has become embroiled in scandals involving fabricated study results. It surfaced in 2009 that Scott S Reuben, a Massachusetts anaesthesiologist and researcher, had faked data for 21 studies on major medications. Several of the drugs reviewed in Reuben’s studies, including Wyeth’s antidepressant, Effexor FX, were shown in a favourable light.

Evidence suggests that Reuben is not alone in his dishonesty. A 2013 article appearing in The Economist entitled “Unreliable Research: Trouble at the Lab” covers the work of Dr. Daniele Fanelli of the University of Edinburgh, who has studied the flaws of academic research outcomes. The article explains that fraud is very likely second to incompetence in generating erroneous results, though it is hard to tell for certain. Dr Fanelli has looked at 21 different surveys of academics (mostly in the biomedical sciences but also in civil engineering, chemistry and economics) carried out between 1987 and 2008. Only 2% of respondents admitted falsifying or fabricating data, but 28% of respondents claimed to know of colleagues who engaged in questionable research practices.

Collusion and deception have become hallmarks of the medical establishment. Here are some additional examples of psychiatry’s corruption by the pharmaceutical cartel.

A 2012 study carried out by psychologist Lisa Cosgrove and her colleagues examining the conflicts of interest in DSM panel members, revealed how the stranglehold of Big Pharma on psychiatric medicine has only increased in recent years. The authors of the study noted that “69% of the DSM-5 task force members report having ties to the pharmaceutical industry. This represents a relative increase of 21% over the proportion of DSM-IV task force members with such ties (57% of DSM-IV task force members had ties).”

Cosgrove goes on to point out that panel members are eligible to help create the DSM as long as they are not paid more than $10,000 from drug companies per year (through consultancies and other jobs). In addition, members are permitted to have up to $50,000 in stock holdings in pharmaceutical firms and still serve in their position.

The American Psychiatric Association meets in secret to develop the DSM. All task force members are required by the APA to sign non-disclosure agreements. This practice has been assailed by many, even former DSM chairman Robert Spitzer, who stated in an interview that “When I first heard about this agreement, I just went bonkers … transparency is necessary if the document is to have credibility.”

In March 2009, The APA made an announcement that it would phase out the practice of accepting contributions from pharmaceutical companies for medical education seminars and food provided at conventions. The pledge was short lived, however. Less than two months later the organisation accepted $1.7 million from Big Pharma for its yearly convention in San Francisco.

Groups such as the National Alliance on Mental Illness (NAMI) and the Anxiety and Depression Association of America (ADAA), which were allegedly founded to advocate on behalf of people with mental disorders, have since been exposed as nothing more than front groups created to push Big Pharma’s profit-driven agenda.

In the 1970s and 1980s, leaders at the National Institute of Mental Health played a key role in helping found these groups, which have effectively lobbied lawmakers in Washington and state capitols to fund more research into psychiatry. These organizations have enjoyed a steady stream of generous financial support from drug makers for years. Congressional records reflect that from 2006-2008, the pharmaceutical cartel poured $23 million into NAMI coffers, accounting for about 75% of its donations.

Given the overwhelming evidence implicating modern psychiatry as a sick and twisted farce designed to profit from human suffering, how could it be that this issue doesn’t receive any substantive media coverage? Why hasn’t this been exposed by The New York Times, Dateline, and 60 Minutes? Could it be the hundreds of millions of dollars in advertising that the corporate media receives from Big Pharma each year? Perhaps this could lead to self-censorship.

The Dangers of SSRIs

We will now take a deeper look at the dangers of associated with SSRIs, particularly Prozac. This new drug consists of the single active isomer of Celexa.). The most controversial issue surrounding the use of SSRIs – a possible connection to suicidal thoughts and behaviour in some users – made news in mid-2003 when the Food and Drug Administration recommended that Paxil not be used to treat depressed children and adolescents because regulators were reviewing reports from clinical trials of an increased risk of suicidal thinking and suicide attempts in young users of the drug.

Zoloft, Paxil, and Prozac were the top-selling antidepressants in the US in 2001, and antidepressants themselves were the largest category of prescription drug that year, with US retail sales of $12.5 billion. Prozac was the leading antidepressant worldwide in 2000, but its share of prescriptions has been declining since the mid-1990s due to competition from other drugs and from generic fluoxetine. Eli Lilly’s US sales of fluoxetine products fell 73% in 2002 following the introduction of generic fluoxetine in the US in August 2001. Generic paroxetine and fluvoxamine also are available on the US market.

Although the Prozac era has ended for Eli Lilly, the availability of less costly generics means that fluoxetine may be more affordable for tens of millions of uninsured people. And in addition to gaining approval for Prozac for indications besides depression (obsessive-compulsive disorder, bulimia nervosa, and panic disorder), Eli Lilly now markets two Prozac-related products that have their own patents: Sarafem is the version of Prozac approved in 2000 for the treatment of premenstrual dysphoric disorder (PMDD). It was the first prescription drug in the US with this indication. The second drug is Prozac Weekly, intended for the longer-term treatment of depression when symptoms have stabilised. It was approved in 2001.
IMS Health has noted a trend toward “lifestyle indications” for antidepressants. In addition to major depression and OCD, both

Paxil and Zoloft are indicated for panic disorder, posttraumatic stress disorder, and social anxiety disorder. Zoloft also is approved for premenstrual dysphoric disorder, while Paxil also is approved for generalised anxiety disorder.
Doctors, for their part, prescribe SSRIs for a wide range of conditions, such as headaches, substance abuse, eating disorders, back pain, impulsivity, upset stomach, irritability, hair pulling, nail biting, premature ejaculation, sexual addictions, and attention deficit disorder.

One growing market for SSRIs is their use with children, even though some studies have found that antidepressants are no more effective than placebos in these patients. A study in the Journal of the American Medical Association in 2000 found that psychotropic medications prescribed to pre-schoolers had “increased dramatically between 1991 and 1995” in the three sites studied. An analysis of prescription claims among young Medicaid patients in North Carolina found that the use of Ritalin-type stimulants and Prozac-type antidepressants among children rose dramatically in the 1990s and that more were taking both drugs at once. In 1998, 10.7% of children aged 6 to 14 were receiving stimulants and 1.7% were receiving SSRIs (30% of these also took stimulants). Lead author Jerry Rushton, MD, MPH, stated, “… the consistent increase in SSRI use and in dual prescriptions is especially surprising. We need further information about whether this is due to new unrecognised mental disorders, substitution for other therapies, or over-prescription.”

Serotonin and side effects

Prozac relieves depression by affecting the level of serotonin, a neurotransmitter that connects receptor sites and fires nerve cells. Joseph Glenmullen, MD, a clinical instructor in psychiatry at Harvard Medical School, explains in his book “Prozac Backlash” that the drug inhibits the reuptake of serotonin – a process in which a cell that releases this chemical messenger reabsorbs any unused portion of it. By blocking the reuptake of this neurotransmitter, Prozac boosts the level of serotonin and prolongs the serotonin signals in the brain.


NOTE: This article is for informational purposes only and is not intended to replace medical or nutritional advice for which you should consult a suitably qualified physician and/or dietitian.


I supply WELLNESS Newsletters to my patients and all other parties who are interested in optimizing their health and wellness potential. ANTRAC WELLNESS Newsletters are jam-packed full of current powerful health-related information to help you attain optimal wellness and vitality and start living life to the full. Did I mention that the Newsletters are FREE? To confirm my promise of supplying vital information on all health issues, CLICK on “Wellness Newsletters” Navigation Bar above to sample the rich contents of the Newsletters.

If YOU haven’t already signed up and you would like to receive future ANTRAC WELLNESS Newsletters every 3 weeks hot off the press to your inbox, just click the Opt-In link below and supply your Email Address, First Name and Last Name. Subscription is absolutely FREE. How easy is that? I do NOT send out SPAM or supply your details to anyone else.